Amyotrophic Lateral Sclerosis (ALS) Market Size Outlook Analysis 2022-2029

Amyotrophic lateral sclerosis treatment market size was valued at USD 537.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2029. Amyotrophic sidelong sclerosis (ALS) is a neurodegenerative problem. It is the most normal sort of engine neuron infection (MND). Amyotrophic parallel sclerosis is a gathering of interesting neurological problems that principally include nerve cells liable for controlling willful muscle development. Amyotrophic parallel sclerosis is otherwise called Lou Gehrig's illness.

Télécharger la présentation

Amyotrophic Lateral Sclerosis (ALS) Market Size Outlook Analysis 2022-2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


More Related